Owner Prescient Neuropharma Inc.

Service Freehills

Various Convention priorty claimed: 7 November 2000, Canada, No. 1081818, in respect of NEUROLOGICAL DISEASE THERAPEUTIC AGENTS; PHARMACEUTICALS FOR DEGENERATIVE NERVE DISEASES; LIVING CELLS WHICH PRODUCE MOLECULES TO RESCUE AND PRESERVE NERVE CELLS; BIOASSAY SYS

Class 5 Pharmaceutical preparations, including neurological disease therapeutic agents, and pharmaceuticals for degenerative nerve diseases; living cells, including living cells which produce molecules to rescue and preserve nerve cells; bioassay systems, including bioassay systems to determine whether molecules selectively prevent death of nerve cells

Class 40 Custom manufacture of cell lines and molecules for others

Class 42 Biotechnology research and development services; providing access to cell lines for research and development by others; bioassay services